Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

175
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

138
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Urogenital chlamydia trachomatis treatment failure with azithromycin: A meta-analysis (Review Article)

Pages

  603-620

Abstract

 Background: Chlamydia trachomatis is one of the most common pathogens transmitted through the genital tract in humans that leads to Urogenital infection. Objective: Given the high prevalence of chlamydia infection and its adverse effects on the health of women and men, the present Meta-analysis was conducted to determine the rate of Treatment failure with Azithromycin. Materials and Methods: Databases including MEDLINE, ISI-Web of Science, PubMed, EMBASE, Scopus, ProQuest, and Science Direct were searched for articles published between 1991 and 2018. The quality of the selected articles was assessed using the Cochrane risk of bias assessment tool. Heterogeneity was determined using the I2 and Cochrane Q-Test. Subgroup analysis and meta-regression were used to compare the prevalence rates on different levels of the variables. Results: Atotal of 21 articles that met the inclusion criteria were ultimately assessed. The pooled estimate of Azithromycin failure rate was 11. 23% (CI 95%: 8. 23%-14. 24%). Also, the Azithromycin failure rate was 15. 87% (CI 95%: 10. 20%-21. 54%) for the treatment of urethritis, 7. 41% (CI 95%: 0. 60%-14. 22%) for cervicitis, and 7. 14% (CI 95%: 10. 90%-3. 39%) for genital chlamydia. The pooled estimate of failure rate difference was 2. 37% (CI 95%: 0. 68%-4. 06%), which shows that Azithromycin has a higher failure rate in the treatment of chlamydia compared to doxycycline and other examined medications. The meta-regression results showed that the patient’ s age contributes significantly to the heterogeneity for Azithromycin Treatment failure rate ( = 0. 826; p = 0. 017). Conclusion: Azithromycin has a higher failure rate than doxycycline and other studied medications in treating Urogenital chlamydia infections.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    MOHAMMADZADEH, FARNAZ, DOLATIAN, MAHROKH, JORJANI, MASOUMEH, AFRAKHTEH, MARYAM, ALAVI MAJD, HAMID, ABDI, FATEMEH, & PAKZAD, REZA. (2019). Urogenital chlamydia trachomatis treatment failure with azithromycin: A meta-analysis (Review Article). INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE (IRANIAN JOURNAL OF REPRODUCTIVE MEDICINE), 17(9), 603-620. SID. https://sid.ir/paper/296593/en

    Vancouver: Copy

    MOHAMMADZADEH FARNAZ, DOLATIAN MAHROKH, JORJANI MASOUMEH, AFRAKHTEH MARYAM, ALAVI MAJD HAMID, ABDI FATEMEH, PAKZAD REZA. Urogenital chlamydia trachomatis treatment failure with azithromycin: A meta-analysis (Review Article). INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE (IRANIAN JOURNAL OF REPRODUCTIVE MEDICINE)[Internet]. 2019;17(9):603-620. Available from: https://sid.ir/paper/296593/en

    IEEE: Copy

    FARNAZ MOHAMMADZADEH, MAHROKH DOLATIAN, MASOUMEH JORJANI, MARYAM AFRAKHTEH, HAMID ALAVI MAJD, FATEMEH ABDI, and REZA PAKZAD, “Urogenital chlamydia trachomatis treatment failure with azithromycin: A meta-analysis (Review Article),” INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE (IRANIAN JOURNAL OF REPRODUCTIVE MEDICINE), vol. 17, no. 9, pp. 603–620, 2019, [Online]. Available: https://sid.ir/paper/296593/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top